2019 annual financial data
Lyell Immunopharma 2019 Net income
Direct answer
Net income was -129,377,000 USD.
Operating income was -102,089,000 USD and net income was -129,377,000 USD.
Operating cash flow was 39,474,000 USD.
Get free Lyell Immunopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 657,000 USD
- Operating income
- -102,089,000 USD
- Net income
- -129,377,000 USD
- Operating cash flow
- 39,474,000 USD